Accretion Nutraveda

ANL

Q: How strong is Accretion Nutraveda balance sheet?

Balance sheet of Accretion Nutraveda is strong.It shouldn't have solvency or liquidity issues.

Q: Is the debt of Accretion Nutraveda increasing or decreasing?

The net debt of Accretion Nutraveda is decreasing.Latest net debt of Accretion Nutraveda is ₹2.95 Crs as of Mar-26.This is less than Mar-25 when it was ₹3.84 Crs.

Q: Is Accretion Nutraveda stock expensive?

There is insufficient historical data to gauge this.Latest PE of Accretion Nutraveda is 78.42

Price

Nano Cap

₹205 Cr.

New to Zerodha? Sign-up for free.

Accretion Nutraveda Ltd. manufactures Ayurvedic and nutraceutical products, including tablets, capsules, liquids, powders, and personal care items. The company blends traditional Ayurveda with modern… More

Accretion Nutraveda Ltd. manufactures Ayurvedic and nutraceutical products, including tablets, caps… More

Low

150

52W Range

High

300

40.42

Sector PE

30.27

P/B

Div.Yield

ROE

48.85%

EBIDTA

ROCE

51.16

EPS

New to Zerodha? Sign-up for free.

Get instant stock alerts

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

Coming soon

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

ANL
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

ANL
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

This data is currently unavailable for this company.

Events:

Quarterly Results

Announcement Date

May 08, 2026

More Nano Cap Ideas

See similar 'Nano' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Accretion Nutraveda do?

Accretion Nutraveda is engaged in manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, and Oral Powders, etc. It is a healthcare focused company specialising in contract manufacturing, serving domestic as well as export markets in various countries. It offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science.

Who are the competitors of Accretion Nutraveda?

Accretion Nutraveda major competitors are Walpar Nutritions, Influx Healthtech. Market Cap of Accretion Nutraveda is ₹205 Crs. While the median market cap of its peers are ₹343 Crs.

Is Accretion Nutraveda financially stable compared to its competitors?

Accretion Nutraveda seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Accretion Nutraveda pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Accretion Nutraveda latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Accretion Nutraveda allocated its funds?

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

How strong is Accretion Nutraveda balance sheet?

Balance sheet of Accretion Nutraveda is strong. It shouldn't have solvency or liquidity issues.

Is the profitablity of Accretion Nutraveda improving?

Yes, profit is increasing. The profit of Accretion Nutraveda is ₹4.41 Crs for TTM, ₹2.61 Crs for Mar 2025 and ₹0.82 Crs for Mar 2024.

Is the debt of Accretion Nutraveda increasing or decreasing?

The net debt of Accretion Nutraveda is decreasing. Latest net debt of Accretion Nutraveda is ₹2.95 Crs as of Mar-26. This is less than Mar-25 when it was ₹3.84 Crs.

Is Accretion Nutraveda stock expensive?

There is insufficient historical data to gauge this. Latest PE of Accretion Nutraveda is 78.42

Has the share price of Accretion Nutraveda grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Accretion Nutraveda?

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Accretion Nutraveda is 73.48% and last quarter promoter holding is 73.48%.

Are mutual funds buying/selling Accretion Nutraveda?

There is Insufficient data to gauge this.

ANL

Share Price

Financials

Summary

Profit & Loss

Balance sheet

Cashflow

Revenue mix

Product wise

Location wise

Shareholdings

Peers

Forensics

Recent events

News

Corporate Actions

Events:

Quarterly Results

More Nano Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Accretion Nutraveda do?

Who are the competitors of Accretion Nutraveda?

Is Accretion Nutraveda financially stable compared to its competitors?

Does Accretion Nutraveda pay decent dividends?

How has Accretion Nutraveda allocated its funds?

How strong is Accretion Nutraveda balance sheet?

Is the profitablity of Accretion Nutraveda improving?

Is the debt of Accretion Nutraveda increasing or decreasing?

Is Accretion Nutraveda stock expensive?

Has the share price of Accretion Nutraveda grown faster than its competition?

Is the promoter bullish about Accretion Nutraveda?

Are mutual funds buying/selling Accretion Nutraveda?